The market for real-world evidence (RWE) solutions market is expected to grow CAGR of ~10% during the forecast period. The ...

The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

Barclays on Thursday downgraded the contract research organizations IQVIA Holdings (NYSE:IQV), ICON PLC (NASDAQ:ICLR), and Fortrea Holdings (NASDAQ:FTRE), arguing that the Trump administration’s ...

The stock's rise snapped a four-day losing streak.

BofA lowered the firm’s price target on Iqvia (IQV) to $190 from $235 and keeps a Buy rating on the shares. Sentiment for Life Sciences and ...

Stifel lowered the firm’s price target on Iqvia (IQV) to $211 from $261 and keeps a Buy rating on the shares. President Trump has discussed plans for tariffs on pharma imports, and Iqvia’s ...

IQVIA Holdings Inc. closed 42.44% below its 52-week high of $252.88, which the company reached on August 29th.

Fintel reports that on April 10, 2025, Barclays downgraded their outlook for IQVIA Holdings (NYSE:IQV) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 58.50% Upside As of April 2, ...

The chief financial officer of crypto marker maker Portofino Technologies, Mark Blackborough, has recently left the business. "We can confirm that our CFO is transitioning out of the business.

Oncology Clinical Trials Market has been steadily growing over the years due to increasing incidence of cancer, advancements ...